Abstract
Background
The 24-h head computed tomography (CT) scan following intravenous tissue plasminogen activator or mechanical thrombectomy (MT) is currently part of most acute stroke protocols. However, as evidence emerges regarding who is at highest risk for treatment complications, the utility of routine neuroimaging for all patients has become less clear.
Methods
Four hundred seventy-five patients presenting with acute ischemic stroke to Johns Hopkins Bayview Medical Center between 2004 and 2018 and treated with intravenous tissue plasminogen activator and/or MT were evaluated. Neuroimaging performed during the first 48 h of hospitalization was reviewed for edema, hemorrhagic transformation (HT), or other findings altering management. Early imaging (< 24 h), performed for neurologic deterioration, was compared with imaging performed per protocol (24 ± 6 h). Factors predictive of radiographically and clinically significant findings on per-protocol imaging were determined.
Results
One hundred fifty-three patients (32%) underwent early imaging. These patients generally had more severe strokes. HT was found in 15% of cases. For the remaining patients (n = 322), imaging at 24 h impacted acute management for only 24 patients: resulting in emergent hemicraniectomy in 1 (0.3%) and leading to additional imaging to monitor asymptomatic HT or edema in 23 (7.1%). Advanced age, higher stroke severity, MT, and atrial fibrillation were associated with significant findings on the 24-h CT scan. Only 2 of the 24 patients had an initial National Institutes of Health Stroke Scale score of < 7.
Conclusions
The 24-h head CT scan does not change management for most patients, particularly those with low National Institutes of Health Stroke Scale scores who do not undergo MT. Consideration should be given to removing routine follow-up imaging from postthrombolysis protocols in favor of an examination-based approach.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
In 1995, tissue plasminogen activator (tPA) was first shown to significantly improve outcomes for patients presenting with acute ischemic stroke [1]. Advancements in technology have resulted in extension of the treatment window and augmentation of recanalization with mechanical thrombectomy (MT) [2]. However, reperfusion of injured tissue confers risk of hemorrhagic transformation (HT) and reperfusion injury [1]. Therefore, patients who receive intravenous (IV) tPA or MT are typically monitored in an intensive-care-like setting (intensive care unit or intermediate care unit) for 24 h post treatment to detect signs of stroke progression, symptomatic HT, and herniation. A routine 24-h noncontrast head computed tomography (CT) scan was part of the original postthrombolysis protocol [1] and is currently recommended in the National Institute of Neurological Disorders and Stroke and American Heart Association guidelines for acute stroke treatment [3] to radiographically monitor for worsening [3] and predict the likelihood of future stroke [4].
As our knowledge surrounding the risks and benefits of thrombolysis improves, treatment protocols for acute ischemic stroke have evolved, not only extending treatment windows [2] but also including elderly patients [5] and no longer requiring preintervention coagulation studies [6]. The risk of HT is relatively small [1], especially in those with low initial National Institutes of Health Stroke Scale (NIHSS) scores, and typically occurs within the first 12 h of admission [7], but we can now further stratify an individual’s risk for treatment complications, recognizing that factors such as stroke size, age, and renal function are important to consider [8]. In this setting, it is possible that, despite the original benefits of a 24-h noncontrast head CT scan, it may no longer be necessary for all patients, as it exposes them to additional radiation [9], increases health care costs, and delays patient throughput. American Heart Association guidelines are being adapted to include consideration of magnetic resonance imaging (MRI) as an alternative imaging modality to CT; however, a majority of institutions continue to use the more traditional approach, and nearly all continue to rely on some form of 24-h neuroimaging to make triage decisions regarding appropriate level of care. This may be unnecessary, and an approach to order follow-up CT imaging based on changes in neurological examination fundings may be more appropriate, with MRI obtained at some point during the hospitalization as part of the standard stroke workup, but not required at 24 h, to determine final size and etiology of the infarct.
This study evaluates the utility of the routine 24-h noncontrast head CT scan as part of the postthrombolysis protocol by identifying the proportion of per-protocol neuroimaging studies resulting in alterations to patient management. In addition, we identify factors associated with clinically significant scans that could help to tailor this practice to the individuals most likely to benefit.
Methods
A prospectively collected cohort of consecutive patients presenting with acute ischemic stroke to the Johns Hopkins Bayview Medical Center between October 2004 and June 2018 who were treated with IV tPA with or without MT was recruited into our institutional-review-board-approved stroke registry. For this study, approved by our institutional review board, we retrospectively determined the significance of the 24-h head CT scan within the cohort. Given the observational nature, informed consent was not required. Information regarding patient demographics (age, race, sex), past medical history (atrial fibrillation, smoking, diabetes, prescribed use of antiplatelets or anticoagulants), stroke characteristics (admission NIHSS score, stroke volume, degree of white matter disease [10]), treatment details (IV tPA, MT, time to thrombolysis), and medical variables (admission systolic blood pressure, peak systolic blood pressure, serum creatinine level, platelet count, low-density lipoprotein level, international normalized ratio) was obtained through chart review.
Neuroimaging
Radiology reports of all neuroimaging (CT or MRI) performed during the first 48 h of hospitalization were reviewed for the presence of edema, mass effect, herniation, stroke evolution or progression, and hemorrhage. Hypodensities due to ischemia versus those due to edema were differentiated by the presence of mass effect or herniation. Findings, along with infarct location and white matter grading, were confirmed by a board-certified vascular neurologist. Carestream [11], available on our institution’s picture archive and communication system (PACS), was used to automatically calculate infarct volume by using diffusion-weighted imaging sequences for patients with MRI (n = 335). On the basis of time of thrombolysis and subsequent neuroimaging, patients were dichotomized into those undergoing early CT (< 24 h) versus per-protocol (~ 24 h) imaging. Early CT scans were ordered following assessment by the provider, who was notified by nursing for any change in neurological examination findings. Per-protocol scans were performed 24 ± 6 h post treatment as part of the postthrombolysis pathway.
Imaging was categorized into four groups: no acute abnormality/normal CT findings, expected evolution of stroke (hypodensity without significant surrounding edema or mass effect), appearance of edema/mass effect, and presence of hemorrhage. This categorization was confirmed by a board-certified vascular neurologist. Patients with evidence of edema with mass effect or HT were considered to have radiographically significant findings. Additional chart review was performed to determine clinical significance: if imaging changed management, resulting in additional imaging for monitoring, an emergent procedure (such as external ventricular drain or hemicraniectomy), administration of hypertonic saline or mannitol, or alteration in blood pressure goals. Daily progress notes were reviewed for evidence of alterations in goals due to imaging findings. Hemorrhages were further classified as asymptomatic HT or symptomatic intracranial hemorrhage (sICH), defined as the presence of blood on neuroimaging findings corresponding to a clinical deterioration [1].
Statistics
Data were analyzed by using Stata version 14 (Stata Corp, College Station, TX). Differences between those undergoing early CT versus per-protocol imaging, along with differences in the rates of sICH, were compared using Student’s t-tests and χ2 analyses for continuous and categorical variables, respectively. Those undergoing early CT imaging were then removed from analysis, and only those completing per-protocol imaging were reviewed for subsequent analyses. The primary outcome of interest was the percentage of patients undergoing per-protocol imaging that was (1) radiographically or (2) clinically significant. Student’s t-tests (continuous variables) and χ2 analyses (categorical variables) were used to determine factors associated with imaging of radiographic or clinical significance. A p value equal to or less than 0.05 was considered statistically significant.
Results
Four hundred seventy-five patients were admitted and met criteria for inclusion over the study period. Three hundred ninety-eight had been treated with IV tPA alone, 36 with MT alone, and 41 with combination therapy. The average age of the cohort was 67.2 years (SD = 16.3). Fifty-five percent (n = 260) were women, and 28% (n = 133) were African American.
Early Imaging Differences
One hundred fifty-three patients (32.2%) underwent early imaging following thrombolysis due to a change in clinical examination findings. The average time to early imaging was 10.7 h (SD = 5.7). On average, patients who underwent imaging early had greater stroke severity (mean admission NIHSS score 12.5 [SD = 7.1] versus 9.9 [SD = 7.0], p < 0.001; mean infarct volume 81.4 ml [SD = 125.8] versus 37.4 ml [SD = 66.1], p < 0.001) than those who underwent imaging per protocol. Patients with an early CT scan were also more likely to have atrial fibrillation (34.0% versus 20.5%, p = 0.001) and a history of smoking (63.1% versus 52.5%, p = 0.042). Symptomatic hemorrhage rates were significantly higher in the early imaging group (15.0% versus 0.3%, p < 0.001), and they required longer hospital stays (9.1 [SD = 8.5] versus 6.5 days [SD = 6.4], p < 0.001). See Table 1 for further details.
Per-protocol Cohort
Clinically Significant Imaging
The remaining patients (n = 322) were scanned per protocol an average of 25.3 h (SD = 7.7) post thrombolysis. Of these individuals, only one (0.3%) had CT findings that significantly altered care. This patient had a large stroke (final volume 324 ml) with a consistently poor examination funding (admission NIHSS score 9, right middle cerebral artery syndrome) but was taken for emergent hemicraniectomy when the 24-h head CT scan revealed increased edema and blood products. No other patients required hypertonic solutions or other interventions as a direct result of the routine imaging.
Twenty-three (7.1%) patients required additional follow-up scans to monitor for HT or edema. In general, patients who required additional neuroimaging for follow-up monitoring were older (mean age 73.8 years [SD = 15.3] versus 66.1 years [SD = 16.8], p = 0.032) and had a history of atrial fibrillation (43.5% versus 18.9%, p = 0.005) and anticoagulant use (27.3% versus 7.3%, p = 0.001) (see Table 2 for full details). They presented with more severe strokes (admission NIHSS score 14.7 [SD = 5.9] versus 9.51 [SD = 6.9], p = 0.001; mean stroke volume 102.6 ml [SD = 111.8] versus 32.4 ml [SD = 58.9], p = 0.000) and were more likely to have been treated with MT (34.8% versus 6.4%, p = 0.000) than those not requiring additional monitoring. When patients treated with IV tPA alone who underwent routine imaging (n = 274) were considered, only 14 of the per-protocol CT scans led to additional imaging. Only one of these individuals had an NIHSS score of < 7.
Radiographically Significant Imaging
One hundred fourteen patients (35.4%) had normal head CT findings, without evidence of infarct on follow-up imaging, whereas 145 (45.0%) had expected evolution of their stroke. Twenty-six (8.1%) patients showed increasing edema with some mass effect; 22 (6.8%), some evidence of HT; and 15 (4.7%), a combination of both, although only the patient described above was deemed to have an sICH. The average NIHSS score for those with radiographically significant scan findings was 14. Patients with radiographically significant abnormalities on imaging were similar to those requiring additional imaging (Table 2). Although not all patients with evidence of edema or HT underwent reimaging (n = 20 of 65), the majority of patients who underwent reimaging had what we defined as radiographically significant CT scan findings (n = 20 of 23).
Discussion
The 24-h head CT scan was an integral component of the early IV tPA trials to evaluate for HT and monitor for edema. It has been important in helping physician teams to feel comfortable downgrading patients post thrombolysis and gauge infarct evolution. However, over time, our knowledge surrounding the risks and benefits of treatment, along with individuals at highest risk for complications, has improved, resulting in changes to acute stroke protocols, for example, with respect to inclusion criteria and required pretreatment testing [5, 6]. Our study suggests it may also be time to reconsider our posttreatment monitoring practices, as only a small number of patients benefit from a routine 24-h noncontrast head CT scan post thrombolysis. This number decreases further if patients do not have a history of atrial fibrillation, have high admission NIHSS scores, or undergo MT. These findings are consistent with those in a previously published study evaluating 131 patients post IV tPA that found that the findings of a 24-h head CT scan resulted in a change in management (decreased blood pressure goal) for only one patient [12]. A second study evaluating 280 patients from the national Get With the Guidelines Database similarly showed that findings of the 24-h head CT scan had no clinical impact for 95% of asymptomatic patients [13]. Our study is larger and also includes patients post thrombectomy, given that this has now become standard of care for large vessel occlusions [14,15,16,17], and relies on similar posttreatment protocols yet arrives at the same conclusion, suggesting generalizability across stroke centers and independent of method of recanalization. A third study of 100 patients undergoing treatment with IV tPA and/or MT also found that the vast majority of patients with symptomatic hemorrhage underwent imaging outside of routine monitoring because of changes in examination findings [18]. Our study goes one step further, evaluating not only the utility of routine head CT in detecting HT but also its role in alteration of clinical management.
Consistent with the results of others [12], within our cohort, the findings of the 24-h head CT scan resulted in a true change in management for only one patient (0.3%), a 55-year-old man who presented to our comprehensive stroke center with a large vessel occlusion and underwent MT. After ~ 24 h of a persistently poor examination finding, follow-up imaging revealed a large infarct, increasing mass effect, midline shift, and blood products leading to emergent hemicraniectomy. As this case illustrates, monitoring for evolution of large strokes in the days following thrombectomy is important; however, even in these cases, the 24-h follow-up CT image itself may typically be less clinically useful if there is no degradation of examination findings, given that worsening edema peaks 48–72 h post infarct [19].
Although edema tends to occur days after recanalization [19], HT typically occurs much earlier, within the first 8–12 h of reperfusion [7]. Associated by definition with a change in examination findings, these patients were almost exclusively part of the early imaging cohort in our study. The rate of early CT imaging due to neurological decline was higher than previously reported (30% versus 20%) and may be the result of including patients post MT, which carries an increased risk of HT [20]. Findings suggest that the 24-h scan may miss the critical time window (falling after the highest risk of HT but before delayed edema).
Although need for a routine head CT scan at 24 h was rare, we were able to identify factors potentially associated with both clinical and radiographic significance, allowing clinicians to tailor protocols to address highest-risk patients. Not surprisingly, stroke volume, high NIHSS scores, and atrial fibrillation, all associated with larger, more severe strokes, were significant. This is consistent with the literature that more severe strokes are at higher risk for both early and delayed complications [21], likely because of the friability of the tissue involved, propensity for reperfusion injury, and potential for edema due to damaged tissue. Anticoagulation is most commonly used to treat atrial fibrillation in this population, likely leading to its significance; although it could theoretically have also increased the risk for HT. Similarly, those undergoing MT were at greater risk, likely given the larger stroke size, but also possibly because of vessel manipulation. Prior studies have shown higher rates of both asymptomatic and symptomatic hemorrhage in this group [14,15,16,17, 20].
It is also important to point out that for some patients, the 24-h head CT scan may prove reassuring to their treating physicians that current treatment protocols are adequate or that the patient is ready to be downgraded to a lower level of care. However, we would argue that, given the data, choosing an alternative time to imaging, such as 48 h post infarct, when risk for cerebral edema is greater, or opting to use the clinical examination findings alone, particularly for those with smaller strokes, may be more appropriate.
Although there may be some patients who benefit from a 24-h routine head CT scan post thrombolysis, our study illustrates that for the majority of individuals, it is likely unnecessary, along with other modalities (MRI). The current need for routine neuroimaging often keeps individuals in the intensive care unit, even when clinically appropriate for downgrading. This delay can impact both patient care and hospital throughput. In addition, frequent head CT scans increase radiation exposure, which can increase risk of future cancer [9] diagnosis, and increases health care costs. Although these considerations should certainly not be the only factors dictating care, for patients with low NIHSS scores who are neurologically stable, consideration should be given to forgoing the 24-h CT in favor of MRI performed electively at some point during the hospitalization as part of the stroke workup.
Our study is not without limitations. It included a cohort of patients from a single urban comprehensive stroke center. However, findings are consistent with those of prior studies, suggesting generalizability to other populations. This may not be true for centers that do not routinely obtain MRI as part of the stroke workup; however, we believe this practice to be relatively uncommon and would still advocate for following the clinical examination. In addition, we chose to include patients who had received both IV tPA and MT. Although this resulted in a heterogenous population, these treatments are now routinely performed as the current standard of care and share similar posttreatment monitoring protocols. It is important to point out that there has been a shift in treatment paradigms over time and that rates of MT have increased only recently, biasing our cohort to those treated with IV tPA alone; however, our results were consistent for patients over the entire study period and suggest that the 24-h head CT scan may not be needed for stable patients in either group. We also chose to use radiology reports to screen for radiographic significance and evidence of HT or edema. To avoid concern for inconsistency across radiologists, findings were confirmed by a board-certified neurologist for this study. Finally, because of the retrospective analysis of CT findings, determining whether a CT scan performed around the 24-h posttreatment mark was done for clinical indications or per protocol and whether the routine CT scan directly impacted clinical care could theoretically be difficult. However, extensive chart review was performed to determine the relationship between changes in examination findings, imaging orders, and changes to the treatment plan. In addition, findings for the majority of 24-h CT scans were either entirely normal or showed suspected stroke evolution. The small number of remaining cases was reviewed and discussed among two board-certified neurologists to ensure accuracy and consistency.
Regardless of limitations, our study illustrates that the routine 24-h noncontrast head CT scan ordered per protocol as part of the postthrombolysis protocol at most stroke centers likely provides little additive information for acute management for the majority of patients. A vast majority of patients at risk for adverse events undergo early imaging because of evidence of clinical deterioration. We advocate consideration be given to removing the 24-h scan entirely in favor of an examination-driven approach or, alternatively, tailoring the practice to the groups at highest risk: those of advanced age, with atrial fibrillation, who present with high NIHSS scores, and who undergo MT.
References
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–7.
Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.
American Heart Association. Acute ischemic stroke: current treatment approaches. Stroke. 2015;46:3020–35.
Mayor S. Brain scan within 24 hours of mild stroke predicts risk of future stroke, study shows. BMJ. 2014;349:g7519.
Cronin CA, Sheth KN, Zhao X, Messe SR, Olson DM, Hernandez AF, et al. Adherence to Third European Cooperative Acute Stroke Study 3- to 4.5-hour exclusions and association with outcome: data from Get with the Guidelines-Stroke. Stroke. 2014;45(9):2745–9.
Gottesman RF, Alt J, Wityk RJ, Llinas RH. Predicting abnormal coagulation in ischemic stroke: reducing delay in rt-PA use. Neurology. 2006;67(9):1665–7.
Chang A, Llinas EJ, Chen K, Llinas RH, Marsh EB. Shorter intensive care unit stays? The majority of post-intravenous tPA (tissue-type plasminogen activator) symptomatic hemorrhages occur within 12 hours of treatment. Stroke. 2018;49(6):1521–4.
Marsh EB, Gottesman RF, Hillis AE, Urrutia VC, Llinas RH. Serum creatinine may indicate risk of symptomatic intracranial hemorrhage after intravenous tissue plasminogen activator (IV tPA). Medicine (Baltimore). 2013;92(6):317–23.
Center for Devices and Radiological Health. What are the radiation risks from CT? Silver Spring: US Food and Drug Administration; 2017. p. 2017.
Manolio TA, Kronmal RA, Burke GL, Poirier V, O’Leary DH, Gardin JM, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study Stroke. 1994;25(2):318–27.
Carestream Health. Carestream vue PACS;2019.
Guhwe M, Utley-Smith Q, Blessing R, Goldstein LB. Routine 24-hour computed cosmography brain scan is not useful in stable patients post intravenous tissue plasminogen activator. J Stroke Cerebrovasc Dis. 2016;25(3):540–2.
Sevilis T, Gomez LM, Shah N, et al. The effect of 24 hour post-intravenous alteplase CT head on management decisions: a single center experience. In: Proceedings of the AAN Annual Meeting; 2016 Apr 15–21; Vancouver, Canada.
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019–30.
Campbell BCV, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009–18.
Berkhemer OA, Fransen PSS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11–20.
Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296–306.
Nalleballe K, Jasti M, Jadeja N, Onteddu S. 24 hours post tPA surveillance head CT, what does it add to patient care. Neurology. 2015;84(14 Suppl):P6.231.
Dhar R, Yuan K, Kulik T, Chen Y, Heitsch L, An H, et al. CSF volumetric analysis for quantification of cerebral edema after hemispheric infarction. Neurocrit Care. 2016;24(3):420–7.
Sussman ES, Connolly ES Jr. Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke. Front Neurol. 2013;4:69.
Saver JL. Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm. Stroke. 2007;38(8):2279–83.
Funding
The authors report no funding sources for this work, although Dr. Marsh is supported in part through an American Heart Association Innovative Project grant (18IPA34170313) and an R21 award through the National Institutes of Health/National Institute on Aging (1 R21 AG068802-01).
Author information
Authors and Affiliations
Contributions
EJL was responsible for data collection, analysis, and manuscript preparation. AM was responsible for data collection. SK was responsible for manuscript preparation and editing. EBM was responsible for study design, analysis, manuscript preparation, and study oversight. All authors have read and approved the submitted manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflicts of interest.
Ethical Approval/Informed Consent
This article adheres to ethical guidelines. The study is institutional review board approved. Informed consent was not required given the observational nature.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Llinas, E.J., Max, A., Khan, S. et al. The Routine Follow-up Head CT: Is it Still a Necessary Step in the Thrombolysis Pathway?. Neurocrit Care 36, 595–601 (2022). https://doi.org/10.1007/s12028-021-01348-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-021-01348-4